Article
Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jan 2018
Arbour Kathryn C, Jordan Emmett, Kim Hyunjae Ryan, Dienstag Jordan, Yu Helena A, Sanchez-Vega Francisco, Lito Piro, Berger Michael, Solit David B, Hellmann Matthew, Kris Mark G, Rudin Charles M, Ni Ai, Arcila Maria, Ladanyi Marc, Riely Gregory J
Abstract excerpt
Purpose:KRAS mutations occur in approximately 25% of patients with non-small cell lung cancer (NSCLC). Despite the uniform presence of KRAS mutations, patients with KRAS-mutant NSCLC can have a heterogeneous clinical course. As the pattern of co-occurring mutations may describe different biological subsets of patients with KRAS-mutant lung adenocarcinoma, we explored the effects of co-occurring mutations on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
